Ranitidine 150
NDC Package 68998-397-93
Package Information
Ranitidine 150 is a . Marketed by Marc Glassman, Inc., this product is identified by NDC 68998-397 and is authorized under FDA application ANDA078192.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68998 - Marc Glassman, Inc.
- 68998-397 - Ranitidine 150
- 68998-397-93 - 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK
- 68998-397 - Ranitidine 150
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68998-397-93 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, coated in 1 blister pack of Ranitidine 150, labeled by Marc Glassman, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Marc Glassman, Inc. on October 01, 2018. The current certification is valid through April 30, 2021.
How is this Marc Glassman, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68998039793. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.